|
|
|
|
Direct Cost |
Indirect Cost |
|
1D43TW011544-01 |
Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases (NCDs) (V-BRCH) |
VANDERBILT UNIVERSITY MEDICAL CENTER |
FIC |
$285,900 |
$17,330 |
$303,230 |
1DP5OD029586-01 |
Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics |
VANDERBILT UNIVERSITY MEDICAL CENTER |
OD |
$250,000 |
$182,500 |
$432,500 |
1F32CA254070-01 |
Investigating concurrent Ras-pathway inhibition to optimize response to anti-PD-1 therapy in NRAS-mutant melanoma |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NCI |
$71,430 |
|
$71,430 |
1F32GM139303-01 |
The mechanistic basis for toxin secretion in Clostridioides difficile |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NIGMS |
$64,926 |
|
$64,926 |
1F32HD100087-01A1 |
Cell-to-cell communication within gestational membranes in response to bacterial infection |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NICHD |
$67,446 |
|
$67,446 |
1G11TW011529-01 |
UEM-Vanderbilt Academic Partnership for Enhancements in Research (APER) |
VANDERBILT UNIVERSITY MEDICAL CENTER |
FIC |
$96,069 |
$7,229 |
$103,298 |
1K01AA029042-01 |
Alcohol-Associated Syndemic and Microbiome Evaluation and Targeted Treatment in Persons Living with HIV |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NIAAA |
$151,189 |
$12,072 |
$163,261 |
1K01CA245231-01 |
Activation of transposable elements as an endogenous source of neoepitopes and mediators of tumor immunogenicity |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NCI |
$115,017 |
$9,201 |
$124,218 |
1K01DA050740-01 |
Advancing Treatment Outcomes for Pregnant Women with Opioid Use Disorder |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NIDA |
$159,530 |
$12,250 |
$171,780 |
1K01DK120631-01A1 |
Influence of genetic variation, genetic ancestry, and obesity on gestational diabetes mellitus risk |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NIDDK |
$131,257 |
$10,501 |
$141,758 |
1K01DK123495-01 |
Antioxidant regulation of intestinal homeostasis and disease |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NIDDK |
$135,919 |
$10,874 |
$146,793 |
1K01EB030039-01 |
Development of Advanced MRI for the Thoracolumbar Spinal Cord for Clinical Application |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NIBIB |
$143,654 |
$11,492 |
$155,146 |
1K01HL149989-01A1 |
Identification of Early Metabolomic and Immune Endotypes of Allergy and Asthma: An Integrated Multiomics Approach |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NHLBI |
$150,000 |
$11,835 |
$161,835 |
1K08AI151100-01 |
Defining the impact of zinc on Streptococcus agalactiae biofilm and colonization |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NIAID |
$171,700 |
$13,736 |
$185,436 |
1K08CA240901-01A1 |
The role of Wnt signaling in aggressive thyroid carcinoma |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NCI |
$212,542 |
$17,003 |
$229,545 |
1K08CA241351-01A1 |
Constitutive Integrin Beta1 Signaling in Lung Cancer |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NCI |
$180,341 |
$14,427 |
$194,768 |
1K08DK124686-01 |
EGF Receptor and Notch Signaling in the Pathogenesis of Menetriers Disease |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NIDDK |
$147,876 |
$11,830 |
$159,706 |
1K08HL153786-01 |
The Role of CCR10+ Regulatory T Cells In Hypertension |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NHLBI |
$146,700 |
$11,736 |
$158,436 |
1K08HL153789-01 |
A Role of Isolevuglandin Adducts in Essential Hypertension and Systemic Lupus Erythematosus |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NHLBI |
$146,700 |
$11,736 |
$158,436 |
1K18MH122755-01 |
Harnessing Electronic Health Records to Identify Participants and to Study Health Outcomes in Transition-Age Youth and Adults with Autism Spectrum Disorder |
VANDERBILT UNIVERSITY MEDICAL CENTER |
NIMH |
$158,361 |
$12,669 |
$171,030 |